Oric Pharmaceuticals与拜耳达成临床试验合作与供应协议 为Himalayas-1试验提供Darolutamide

美股速递
Jul 15

Oric Pharmaceuticals宣布,已与拜耳公司签署一项临床试验合作与供应协议。根据协议条款,Oric将向代号为Himalayas-1的临床试验提供其药物Darolutamide。此项合作旨在推进该药物的临床开发进程。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10